Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...
Q3 2025 Earnings Call Transcript November 13, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.04, ...
Vaxart Inc (VXRT) announces a major partnership with Dynavax and reports significant revenue growth, while navigating market ...
Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash. Following a series of setbacks for the biotech, ...
It's that time of year again, when winter bugs seem to be everywhere and if your child is at school or nursery and in close ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Moderna’s third quarter was shaped by sharply lower demand for COVID-19 vaccines, yet the company delivered results above ...
Health bosses are already seeing increased demand for hospital services in Staffordshire and Stoke-on-Trent before the start of winter, it has been revealed.
Doctors have warned of a new and dangerous strain of influenza that is causing very severe illness in children, and senior ...
New details from health officials suggest the whooping cough surge may be part of a national pattern driven by slipping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results